Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism Principles and Definitions • Selectivity – Selectivty8 toxicity9 • Therapeutic index – Toxic dose/ Effective dose • Categories of antibiotics – Bactericidal • Usually antibiotic of choice – Bacteriostatic • Duration of treatment sufficient for host defenses Principles and Definitions • Antibiotic susceptibility testing (in vitro) – Minimum inhibitory concentration (MIC) • Lowest concentration that results in inhibition of visible growth – Minimum bactericidal concentration (MBC) • Lowest concentration that kills 99.9% of the original inoculum Antibiotic Susceptibility Testing Disk Diffusion Test Determination of MIC Str Tet 8 4 2 1 0 Tetracycline (g/ml) MIC = 2 g/ml Ery Chl Amp Zone Diameter Standards for Disk Diffusion Tests Zone diameter (mm) Antimicrobial agent (amt. per disk) and organism R I Enerobacteriacae 11 12-13 Haemophilus spp. 19 Enterococci 16 Tetracycline (30 g) 14 MS Approx. MIC (g/ml) for: S R S 14 32 8 20 4 2 Ampicillin (10 g) 17 15-18 16 19 16 4 Principles and Definitions • Combination therapy – Prevent emergence of resistant strains – Temporary treatment until diagnosis is made – Antibiotic synergism • Penicillins and aminoglycosides • CAUTION: Antibiotic antagonism – Penicillins and bacteriostatic antibiotics • Antibiotics vs chemotherapeutic agents vs antimicrobials Review of Initiation of Protein Synthesis 1 3 2 GTP 30S 1 2 3 GTP Initiation Factors f-met-tRNA mRNA Spectinomycin 3 GDP + Pi P A 70S Initiation Complex 2 50S 1 Aminoglycosides 1 2 GTP 30S Initiation Complex Review of Elongation of Protein Synthesis Tetracycline P A Tu GTP Tu GDP + GTP Ts Fusidic Acid Tu Ts GDP + Pi Pi Ts G G GDP + P A GDP Chloramphenicol GTP G GTP P A P A Erythromycin Survey of Antibiotics Protein Synthesis Inhibitors • Mostly bacteriostatic • Selectivity due to differences in prokaryotic and eukaryotic ribosomes • Some toxicity - eukaryotic 70S ribosomes Antimicrobials that Bind to the 30S Ribosomal Subunit Aminoglycosides (bactericidal) streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical) • Mode of action - The aminoglycosides irreversibly bind to the 16S ribosomal RNA and freeze the 30S initiation complex (30S-mRNAtRNA) so that no further initiation can occur. They also slow down protein synthesis that has already initiated and induce misreading of the mRNA. By binding to the 16 S r-RNA the aminoglycosides increase the affinity of the A site for t-RNA regardless of the anticodon specificity. May also destabilize bacterial membranes. • Spectrum of Activity -Many gram-negative and some gram-positive bacteria; Not useful for anaerobic (oxygen required for uptake of antibiotic) or intracellular bacteria. • Resistance - Common • Synergy - The aminoglycosides synergize with -lactam antibiotics. The -lactams inhibit cell wall synthesis and thereby increase the permeability of the aminoglycosides. Tetracyclines (bacteriostatic) tetracycline, minocycline and doxycycline • Mode of action - The tetracyclines reversibly bind to the 30S ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome. • Spectrum of activity - Broad spectrum; Useful against intracellular bacteria • Resistance - Common • Adverse effects - Destruction of normal intestinal flora resulting in increased secondary infections; staining and impairment of the structure of bone and teeth. Spectinomycin (bacteriostatic) • Mode of action - Spectinomycin reversibly interferes with m-RNA interaction with the 30S ribosome. It is structurally similar to the aminoglycosides but does not cause misreading of mRNA. • Spectrum of activity - Used in the treatment of penicillin-resistant Neisseria gonorrhoeae • Resistance - Rare in Neisseria gonorrhoeae Antimicrobials that Bind to the 50S Ribosomal Subunit Chloramphenicol, Lincomycin, Clindamycin (bacteriostatic) • Mode of action - These antimicrobials bind to the 50S ribosome and inhibit peptidyl transferase activity. • Spectrum of activity - Chloramphenicol - Broad range; Lincomycin and clindamycin - Restricted range • Resistance - Common • Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but is used in the treatment of bacterial meningitis. Macrolides (bacteriostatic) erythromycin, clarithromycin, azithromycin, spiramycin • Mode of action - The macrolides inhibit translocation. • Spectrum of activity - Gram-positive bacteria, Mycoplasma, Legionella • Resistance - Common Antimicrobials that Interfere with Elongation Factors Selectivity due to differences in prokaryotic and eukaryotic elongation factors Fusidic acid (bacteriostatic) • Mode of action - Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-G/GDP complex. • Spectrum of activity - Gram-positive cocci Inhibitors of Nucleic Acid Synthesis Inhibitors of RNA Synthesis Selectivity due to differences between prokaryotic and eukaryotic RNA polymerase Rifampin, Rifamycin, Rifampicin, Rifabutin (bactericidal) • Mode of action - These antimicrobials bind to DNA-dependent RNA polymerase and inhibit initiation of mRNA synthesis. • Spectrum of activity - Wide spectrum but is used most commonly in the treatment of tuberculosis • Resistance - Common • Combination therapy - Since resistance is common, rifampin is usually used in combination therapy. Inhibitors of DNA Synthesis Selectivity due to differences between prokaryotic and eukaryotic enzymes Quinolones (bactericidal) nalidixic acid, ciprofloxacin, ofloxacin, norfloxacin, levofloxacin, lomefloxacin, sparfloxacin • Mode of action - These antimicrobials bind to the A subunit of DNA gyrase (topoisomerase) and prevent supercoiling of DNA, thereby inhibiting DNA synthesis. • Spectrum of activity - Gram-positive cocci and urinary tract infections • Resistance - Common for nalidixic acid; developing for ciprofloxacin Antimetabolite Antimicrobials Inhibitors of Folic Acid Synthesis p-aminobenzoic acid + Pteridine • Basis of Selectivity • Review of Folic Acid Metabolism Sulfonamides Pteridine synthetase Dihydropteroic acid Dihydrofolate synthetase Dihydrofolic acid Trimethoprim Dihydrofolate reductase Tetrahydrofolic acid Methionine Thymidine Purines Sulfonamides, Sulfones (bacteriostatic) • Mode of action - These antimicrobials are analogues of paraaminobenzoic acid and competitively inhibit formation of dihydropteroic acid. • Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections. • Resistance - Common • Combination therapy - The sulfonamides are used in combination with trimethoprim; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains. Trimethoprim, Methotrexate, Pyrimethamine (bacteriostatic) • Mode of action - These antimicrobials binds to dihydrofolate reductase and inhibit formation of tetrahydrofolic acid. • Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections. • Resistance - Common • Combination therapy - These antimicrobials are used in combination with the sulfonamides; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains. Anti-Mycobacterial Antibiotics Para-aminosalicylic acid (PSA) (bacteriostatic) • Mode of action - Similar to sulfonamides • Spectrum of activity - Specific for Mycobacterium tuberculosis Dapsone (bacteriostatic) • Mode of action - Similar to sulfonamides • Spectrum of activity - Used in treatment of leprosy (Mycobacterium leprae) Isoniazid (INH) (bacteriostatic ) • Mode of action - Isoniazid inhibits synthesis of mycolic acids. • Spectrum of activity - Used in treatment of tuberculosis • Resistance - Has developed Antimicrobial Drug Resistance Principles and Definitions • Clinical resistance • Resistance can arise by mutation or by gene transfer (e.g. acquisition of a plasmid) • Resistance provides a selective advantage • Resistance can result from single or multiple steps • Cross resistance vs multiple resistance – Cross resistance -- Single mechanism-- closely related antibiotics – Multiple resistance -- Multiple mechanisms -- unrelated antibiotics Antimicrobial Drug Resistance Mechanisms • Altered permeability – Altered influx • Gram negative bacteria – Altered efflux • tetracycline • Inactivation – -lactamse – Chloramphenicol acetyl transferase Antimicrobial Drug Resistance Mechanisms • Altered target site – Penicillin binding proteins (penicillins) – RNA polymerase (rifampin) – 30S ribosome (streptomycin) • Replacement of a sensitive pathway – Acquisition of a resistant enzyme (sulfonamides, trimethoprim)